Stocks That Hit 52-Week Lows On Friday
During Friday's session, 445 companies made new 52-week lows.
Day One Announces First Patient Dosed In Phase 2 Monotherapy Study In RAF-altered Solid Tumors
Day One Biopharmaceuticals (NASDAQ:DAWN), a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for patients of all ages with genomically-defined cancers, today
Day One Biopharmaceutical Q3 EPS $(0.33) Up From $(0.50) YoY
Day One Biopharmaceutical (NASDAQ:DAWN) reported quarterly losses of $(0.33) per share. This is a 34 percent increase over losses of $(0.50) per share from the same period last year.
The Daily Biotech Pulse: MacroGenics’ Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA’s FDA Nod
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Sept. 7)
The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 26)
Stocks That Hit 52-Week Highs On Thursday
Before 10 a.m. ET on Thursday, 91 companies hit new 52-week highs.